MedTrace Logo

Post-SOPHrology Cancer Patients' anxieTY Report

NCT03707301 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2022-02-08

No results posted yet for this study

Summary

Cancer is pathology with a high impact on patients and relatives quality of life. Most of the time, it is a stressful trial. Professionals have often resort to pharmaceutical solutions, but sometimes, it is not sufficient. So, patients resort to alternative and complementary medicines, as sophrology. In Lucien Neuwirth Cancer Institute, patients can benefit from sophrology.

Anxiety levels have never been reported before and after sessions. Indeed, the present study wants to report anxiety levels before, after, and one and three weeks after session. Levels of satisfaction will also be reported.

Conditions

Interventions

OTHER

Questionnaires

Questionnaires of satisfaction and the Hospital Anxiety and Depression scale.

Sponsors & Collaborators

  • Institut de Cancérologie de la Loire

    collaborator OTHER

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Stéphanie Morisson, MD · Institut de Cancérologie Lucien Neuwirth

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-24
Primary Completion
2021-05-12
Completion
2021-05-12

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03707301 on ClinicalTrials.gov